Vicinitas Therapeutics Funding: $65M Raised, Series A (2022)

Vicinitas Therapeutics funding overview

Vicinitas Therapeutics is based in South San Francisco, California. Vicinitas Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2022. The round record for Vicinitas Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Deerfield Management, Jorge Conde, 5AM Ventures, Andreessen Horowitz, Maverick Capital, Northpond Ventures and 6 others. 12 distinct backers are named across the disclosed rounds.

Vicinitas Therapeutics at a glance

Total raised: $65M
Latest round: Series A
Latest round date: July 2022
Headquarters: South San Francisco, California
Notable investors: Deerfield Management, Jorge Conde, 5AM Ventures, Andreessen Horowitz, Maverick Capital, Northpond Ventures, Vivo Capital, Berkeley Catalyst Fund

Frequently asked about Vicinitas Therapeutics funding

How much has Vicinitas Therapeutics raised?: Vicinitas Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Vicinitas Therapeutics?: Deerfield Management, Jorge Conde, 5AM Ventures, Andreessen Horowitz, Maverick Capital, Northpond Ventures are named among the investors backing Vicinitas Therapeutics.
What was the latest Vicinitas Therapeutics funding round?: The most recent disclosed round is a Series A, announced in July 2022.
Where is Vicinitas Therapeutics based?: Vicinitas Therapeutics is based in South San Francisco, California.
When did Vicinitas Therapeutics last raise?: The last disclosed Vicinitas Therapeutics round closed in July 2022 at Series A.

Round data for Vicinitas Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.

Vicinitas Therapeutics Funding: $65M Raised, Series A (2022)

Vicinitas Therapeutics funding overview

Vicinitas Therapeutics at a glance

Frequently asked about Vicinitas Therapeutics funding

Companies related to Vicinitas Therapeutics (36)

Browse related funding lists (7)